## **Core Concept**
Thalassemia major, also known as beta-thalassemia major or Cooley's anemia, is a severe form of thalassemia that results from mutations in the HBB gene, leading to reduced or absent production of the beta-globin subunit of hemoglobin. The diagnosis of thalassemia major often involves genetic testing and hemoglobin electrophoresis to identify abnormal hemoglobin patterns.

## **Why the Correct Answer is Right**
The correct answer, **HbF (Fetal Hemoglobin)**, is elevated in thalassemia major because the body attempts to compensate for the reduced production of adult hemoglobin (HbA) by continuing to produce fetal hemoglobin. In thalassemia major, there is a significant reduction or absence of beta-globin chains, leading to a decrease in HbA production and a relative increase in HbF and sometimes HbA2 levels. Detecting elevated levels of HbF, along with clinical and other laboratory findings, supports the diagnosis of thalassemia major.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While HbA2 levels can be elevated in some types of thalassemia, such as beta-thalassemia minor, it is not the primary hemoglobin used for the diagnosis of thalassemia major.
- **Option B:** This option seems to refer to a combination or unspecified hemoglobin, which is not directly relevant to the specific diagnosis of thalassemia major.
- **Option D:** This option appears to be a distractor with no clear relevance to the specific hemoglobins identified in thalassemia major.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients with thalassemia major often present with severe anemia, growth retardation, and skeletal changes due to bone marrow expansion. A diagnosis of thalassemia major is confirmed through a combination of clinical findings, complete blood count (CBC), hemoglobin electrophoresis showing elevated HbF and possibly HbA2, and genetic testing.

## **Correct Answer:** .